SCHEMBL105486

Kakonein is a lipid of Polyketides (PK) class. Kakonein is associated with abnormalities such as Fatty Liver, Chronic liver disease, Morphologically altered structure, Hypertensive disease and Cardiovascular Diseases. The involved functions are known as protein expression, Extravasation, Liver damage, mRNA Expression and cell activation. Kakonein often locates in Body tissue, Hepatic, Microvilli, Cytoplasm and Membrane. The associated genes with Kakonein are TJP1 gene, CD14 gene, iberiotoxin, AT-Rich Interactive Domain-Containing Protein 1A and NKS1 gene. The related lipids are dehydrosoyasaponin I and Steroids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of SCHEMBL105486, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with SCHEMBL105486?

SCHEMBL105486 is suspected in Chronic liver disease, Hypertensive disease, Cardiovascular Diseases, Myocardial Infarction, Cerebrovascular accident, Fatty Liver and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with SCHEMBL105486

MeSH term MeSH ID Detail
Endometriosis D004715 29 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Angina Pectoris D000787 27 associated lipids
Brain Infarction D020520 17 associated lipids
Angina, Unstable D000789 14 associated lipids
Glucose Intolerance D018149 13 associated lipids
Amnesia D000647 12 associated lipids
Hypertension, Renovascular D006978 10 associated lipids
Hepatitis, Alcoholic D006519 5 associated lipids
Dyspepsia D004415 5 associated lipids
Per page 10 20 50 | Total 43

PubChem Associated disorders and diseases

What pathways are associated with SCHEMBL105486

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with SCHEMBL105486?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with SCHEMBL105486?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with SCHEMBL105486?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with SCHEMBL105486?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with SCHEMBL105486?

Knock-out

Knock-out are used in the study 'MATE2 mediates vacuolar sequestration of flavonoid glycosides and glycoside malonates in Medicago truncatula.' (Zhao J et al., 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with SCHEMBL105486

Download all related citations
Per page 10 20 50 100 | Total 919
Authors Title Published Journal PubMed Link
Feng CG et al. [Progress in research of aldose reductase inhibitors in traditional medicinal herbs]. 2005 Zhongguo Zhong Yao Za Zhi pmid:16335816
Tian H et al. [Separation and identification of isoflavonoids in Pueraria lobata extracts and its preparations by reversed-phase capillary liquid chromatography coupled with electrospray ionization quadrupole time of flight mass spectrometry]. 2005 Se Pu pmid:16350789
Kirakosyan A et al. Isoflavone levels in five soybean (Glycine max) genotypes are altered by phytochrome-mediated light treatments. 2006 J. Agric. Food Chem. pmid:16390177
Zhou PQ et al. [Clinical observation of puerarin in treating patients with vertebral artery insufficiency due to cervical spondylosis: a report of 123 cases]. 2006 Zhong Xi Yi Jie He Xue Bao pmid:16409979
Delmonte P et al. Determination of isoflavones in dietary supplements containing soy, Red Clover and kudzu: extraction followed by basic or acid hydrolysis. 2006 J Chromatogr A pmid:16413562
Ren F et al. Quantitative determination of puerarin in dog plasma by HPLC and study on the relative bioavailability of sustained release tablets. 2006 J Pharm Biomed Anal pmid:16413737
Zhang S et al. Reversal of chemical-induced liver fibrosis in Wistar rats by puerarin. 2006 J. Nutr. Biochem. pmid:16426832
Gao Q et al. Atractyloside and 5-hydroxydecanoate block the protective effect of puerarin in isolated rat heart. 2006 Life Sci. pmid:16458326
Weiping S et al. Self-assembly of an amphiphilic derivative of chitosan and micellar solubilization of puerarin. 2006 Colloids Surf B Biointerfaces pmid:16466908
He HJ et al. [Effects of sucrose and light on the growth and production of secondary metabolites in Pueraria phaseoloides hairy roots]. 2005 Sheng Wu Gong Cheng Xue Bao pmid:16468362